Antonio D'Alessio (Antonio D Alessio)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Topics

Advanced Non Small Cell Lung Cancer

Prognostic Factors

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature medicine

Journal of personalized medicine

Journal of hepatocellular carcinoma

This page only lists publications with an associated author ORCID identifier.

Publications

David James Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Alexandra Emilia Schlaak, Ciro Celsa, Saskia Killmer, Jesus Miguens Blanco, Caroline Ward, Charalampos-Vlasios Stikas, Openshaw M R, Nicole Acuti, Georgios Nteliopoulos, Cristina Balcells, Hector C Keun, Robert D Goldin, Paul J Ross, Alessio Cortellini, Robert Thomas, Anna Mary Young, Nathan P Danckert, Paul Tait, Julian R Marchesi, Bertram Bengsch, Rohini Sharma
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
David James Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Alexandra Emilia Schlaak, Ciro Celsa, Saskia Killmer, Jesus Miguens Blanco, Caroline Ward, Charalampos-Vlasios Stikas, Openshaw M R, Nicole Acuti, Georgios Nteliopoulos, Cristina Balcells, Hector C Keun, Robert D Goldin, Paul J Ross, Alessio Cortellini, Robert Thomas, Anna Mary Young, Nathan P Danckert, Paul Tait, Julian R Marchesi, Bertram Bengsch, Rohini Sharma
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
David James Pinato, Claudia A M Fulgenzi, Antonio D'Alessio
Immunotherapy at all stages of hepatocellular carcinoma. Nature medicine 30 (3) (2024)
David James Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Alexandra Emilia Schlaak, Ciro Celsa, Saskia Killmer, Jesus Miguens Blanco, Caroline Ward, Charalampos-Vlasios Stikas, Openshaw M R, Nicole Acuti, Georgios Nteliopoulos, Cristina Balcells, Hector C Keun, Robert D Goldin, Paul J Ross, Alessio Cortellini, Robert Thomas, Anna Mary Young, Nathan P Danckert, Paul Tait, Julian R Marchesi, Bertram Bengsch, Rohini Sharma
Safety and preliminary efficacy of pembrolizumab following trans-arterial chemoembolization for hepatocellular carcinoma: the PETAL phase Ib study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
David James Pinato, Claudia A M Fulgenzi, Antonio D'Alessio
Immunotherapy at all stages of hepatocellular carcinoma. Nature medicine 30 (3) (2024)
David James Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Alexandra Emilia Schlaak, Ciro Celsa, Saskia Killmer, Jesus Miguens Blanco, Caroline Ward, Charalampos-Vlasios Stikas, Openshaw M R, Nicole Acuti, Georgios Nteliopoulos, Cristina Balcells, Hector C Keun, Robert D Goldin, Paul J Ross, Alessio Cortellini, Robert Thomas, Anna Mary Young, Nathan P Danckert, Paul Tait, Julian R Marchesi, Bertram Bengsch, Rohini Sharma
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
David James Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Alexandra Emilia Schlaak, Ciro Celsa, Saskia Killmer, Jesus Miguens Blanco, Caroline Ward, Charalampos-Vlasios Stikas, Openshaw M R, Nicole Acuti, Georgios Nteliopoulos, Cristina Balcells, Hector C Keun, Robert D Goldin, Paul J Ross, Alessio Cortellini, Robert Thomas, Anna Mary Young, Nathan P Danckert, Paul Tait, Julian R Marchesi, Bertram Bengsch, Rohini Sharma
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
David James Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Alexandra Emilia Schlaak, Ciro Celsa, Saskia Killmer, Jesus Miguens Blanco, Caroline Ward, Charalampos-Vlasios Stikas, Openshaw M R, Nicole Acuti, Georgios Nteliopoulos, Cristina Balcells, Hector C Keun, Robert D Goldin, Paul J Ross, Alessio Cortellini, Robert Thomas, Anna Mary Young, Nathan P Danckert, Paul Tait, Julian R Marchesi, Bertram Bengsch, Rohini Sharma
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
David James Pinato, Claudia A M Fulgenzi, Antonio D'Alessio
Immunotherapy at all stages of hepatocellular carcinoma. Nature medicine (2024)
Alessio Cortellini, Antonio D'Alessio, Siobhan Cleary, Sebastiano Buti, Melissa Bersanelli, Paola Bordi, Giuseppe Tonini, Bruno Vincenzi, Marco Tucci, Alessandro Russo, Francesco Pantano, Marco Russano, Luigia Stefania Stucci, Maria Chiara Sergi, Martina Falconi, Maria Antonietta Zarzana, Daniele Santini, Francesco Spagnolo, Enrica Teresa Tanda, Francesca Rastelli, Francesca Chiara Giorgi, Federica Pergolesi, Raffaele Giusti, Marco Filetti, Francesca Lo Bianco, Marina Chiara Garassino, Andrea Botticelli, Alain J Gelibter, Marco Siringo, Marco Ferrari, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Michele Ghidini, Olga Nigro, Francesco Grossi, Michele De Tursi, Pietro Di Marino, Paola Queirolo, Sergio Bracarda, Serena Macrini, Alessandro Inno, Federica Zoratto, Enzo Veltri, Chiara Spoto, Maria Grazia Vitale, Katia Cannita, Alessandra Gennari, Daniel Laurence Morganstein, Domenico Mallardo, Lorenzo Nibid, Giovanna Sabarese, Leonardo Brunetti, Giuseppe Perrone, Paolo Antonio Ascierto, Corrado Ficorella, David James Pinato
Type 2 diabetes mellitus and efficacy outcomes from imune checkpoint blockade in patients with cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Vincent Joerg, Bernhard Scheiner, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Martin Schönlein, Lorenz Kocheise, Ansgar Wilhelm Lohse, Samuel Huber, Henning Wege, Ahmed Kaseb, Yinghong Wang, Antony Mathew, Andrew Kuang, Mahvish Muzaffar, Yehia I Abugabal, Shadi Chamseddine, Samuel Phen, Jaekyung Cheon, Pei-Chang Lee, Lorenz Balcar, Anja Krall, Celina Ang, Linda Wu, Anwaar Saeed, Yi-Hsiang Huang, Bertram Bengsch, Lorenza Rimassa, Arndt Weinmann, Rudolf Stauber, James Korolewicz, Matthias Pinter, Amit G Singal, Hong Jae Chon, David J Pinato, Kornelius Schulze, Johann von Felden
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study. Hepatology communications 7 (11) (2023)
Alessio Cortellini, Antonio D'Alessio, David James Pinato
Diabetes and Immune Checkpoint Inhibitors-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (19) (2023)
Antonella Cammarota, Valentina Zanuso, Antonio D'Alessio, Tiziana Pressiani, Silvia Bozzarelli, Nicola Personeni, Lorenza Rimassa
The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials. Expert opinion on investigational drugs 31 (4) (2022)
Nicola Personeni, Tiziana Pressiani, Valentina Zanuso, Andrea Casadei-Gardini, Antonio D'Alessio, Martina Valgiusti, Vincenzo Dadduzio, Francesca Bergamo, Caterina Soldà, Mario Domenico Rizzato, Laura Giordano, Armando Santoro, Lorenza Rimassa
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment. Journal of personalized medicine 12 (10) (2022)
Ambreen Muhammed, Antonio D'Alessio, Andrei Enica, Thomas Talbot, Claudia Angela Maria Fulgenzi, Georgios Nteliopoulos, Robert D Goldin, Alessio Cortellini, David James Pinato
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma. Expert review of molecular diagnostics 22 (3) (2022)
Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Naoshi Nishida, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Vincent E Gaillard, Anwaar Saeed, Brooke Wietharn, Hannah Hildebrand, Linda Wu, Celina Ang, Thomas U Marron, Arndt Weinmann, Peter R Galle, Dominic Bettinger, Bertram Bengsch, Arndt Vogel, Lorenz Balcar, Bernhard Scheiner, Pei-Chang Lee, Yi-Hsiang Huang, Suneetha Amara, Mahvish Muzaffar, Abdul Rafeh Naqash, Antonella Cammarota, Nicola Personeni, Tiziana Pressiani, Rohini Sharma, Matthias Pinter, Alessio Cortellini, Masatoshi Kudo, Lorenza Rimassa, David J Pinato
Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study. Hepatology (Baltimore, Md.) 76 (4) (2022)
Nicola Personeni, Laura Giordano, Angelica Michelini, Antonio D'Alessio, Antonella Cammarota, Silvia Bozzarelli, Tiziana Pressiani, Maria Giuseppina Prete, Maria Teresa Sandri, Sabine Stioui, Luca Germagnoli, Armando Santoro, Lorenza Rimassa, Rossana Mineri
Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study. Journal of personalized medicine 12 (2) (2022)
Antonella Cammarota, Valentina Zanuso, Antonio D'Alessio, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa
Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials. Expert opinion on investigational drugs 31 (4) (2022)
Antonio D'Alessio, Lorenza Rimassa, Alessio Cortellini, David James Pinato
PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future Prospects. Journal of hepatocellular carcinoma 8 (2021)
Nicola Personeni, Tiziana Pressiani, Antonio D'Alessio, Maria Giuseppina Prete, Silvia Bozzarelli, Luigi Terracciano, Arianna Dal Buono, Antonio Capogreco, Alessio Aghemo, Ana Lleo, Romano Fabio Lutman, Massimo Roncalli, Laura Giordano, Armando Santoro, Luca Di Tommaso, Lorenza Rimassa
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors. Cancers 13 (22) (2021)
Antonio D'Alessio, Maria Giuseppina Prete, Antonella Cammarota, Nicola Personeni, Lorenza Rimassa
The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges. Journal of hepatocellular carcinoma 8 (2021)
Antonella Cammarota, Antonio D'Alessio, Tiziana Pressiani, Lorenza Rimassa, Nicola Personeni
Systemic Treatment for Older Patients with Unresectable Hepatocellular Carcinoma. Drugs & aging 38 (7) (2021)
Ambreen Muhammed, Claudia Angela Maria Fulgenzi, Sirish Dharmapuri, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Thomas U Marron, Tomi Jun, Anwaar Saeed, Hannah Hildebrand, Mahvish Muzaffar, Musharraf Navaid, Abdul Rafeh Naqash, Anuhya Gampa, Umut Ozbek, Junk-Yi Lin, Ylenia Perone, Bruno Vincenzi, Marianna Silletta, Anjana Pillai, Yinghong Wang, Uqba Khan, Yi-Hsiang Huang, Dominik Bettinger, Yehia I Abugabal, Ahmed Omar Kaseb, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa, Naoshi Nishida, Luca Di Tommaso, Masatoshi Kudo, Arndt Vogel, Francesco A Mauri, Alessio Cortellini, Rohini Sharma, Antonio D'Alessio, Celina Ang, David James Pinato
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma. Cancers 14 (1) (2021)
Antonio D'Alessio, Antonella Cammarota, Valentina Zanuso, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa
Atezolizumab plus bevacizumab for unresectable or metastatic hepatocellular carcinoma. Expert review of anticancer therapy 21 (9) (2021)
Dominik Pfister, Nicolás Gonzalo Nuñez, Roser Pinyol, Olivier Govaere, Matthias Pinter, Marta Szydlowska, Revant Gupta, Mengjie Qiu, Aleksandra Deczkowska, Assaf Weiner, Florian Müller, Ankit Sinha, Ekaterina Friebel, Thomas Engleitner, Daniela Lenggenhager, Anja Moncsek, Danijela Heide, Kristin Stirm, Jan Kosla, Eleni Kotsiliti, Valentina Leone, Michael Dudek, Suhail Yousuf, Donato Inverso, Indrabahadur Singh, Ana Teijeiro, Florian Castet, Carla Montironi, Philipp K Haber, Dina Tiniakos, Pierre Bedossa, Simon Cockell, Ramy Younes, Michele Vacca, Fabio Marra, Jörn M Schattenberg, Michael E D Allison, Elisabetta Bugianesi, Vlad Ratziu, Tiziana Pressiani, Antonio D'Alessio, Nicola Personeni, Lorenza Rimassa, Ann K Daly, Bernhard Scheiner, Katharina Pomej, Martha M Kirstein, Arndt Vogel, Markus Peck-Radosavljevic, Florian Hucke, Fabian Finkelmeier, Oliver Waidmann, Jörg Trojan, Kornelius Schulze, Henning Wege, Sandra Koch, Arndt Weinmann, Marco Bueter, Fabian Rössler, Alexander Siebenhüner, Sara De Dosso, Jan Philipp Mallm, Viktor Umansky, Manfred Jugold, Tom Luedde, Andrea Schietinger, Peter Schirmacher, Brinda Emu, Hellmut G Augustin, Adrian Billeter, Beat Müller-Stich, Hiroto Kikuchi, Dan G Duda, Fabian Kütting, Dirk-Thomas Waldschmidt, Matthias Philip Ebert, Nuh Rahbari, Henrik E Mei, Axel Ronald Schulz, Jane A McKeating, Nisar Malek, Stephan Spahn, Michael Bitzer, Marina Ruiz de Galarreta, Amaia Lujambio, Jean-François Dufour, Thomas U Marron, Ahmed Kaseb, Masatoshi Kudo, Yi-Hsiang Huang, Nabil Djouder, Katharina Wolter, Lars Zender, Parice N Marche, Thomas Decaens, David James Pinato, Roland Rad, Joachim C Mertens, Achim Weber, Kristian Unger, Rüdiger Klein, Susanne Roth, Zuzana Macek Jilkova, Manfred Claassen, Quentin M Anstee, Bjørt K Kragesteen, Percy A Knolle, Burkhard Becher, Josep M Llovet, Mathias F Heikenwälder
NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature 592 (7854) (2021)
Maria Giuseppina Prete, Antonella Cammarota, Antonio D'Alessio, Valentina Zanuso, Lorenza Rimassa
Current options and future directions of systemic therapy for advanced biliary tract cancer. Exploration of targeted anti-tumor therapy 2 (5) (2021)
Antonio D'Alessio, Nicola Personeni, Tiziana Pressiani, Silvia Bozzarelli, Valeria Smiroldo, Matteo Simonelli, Ana Lleo, Armando Santoro, Lorenza Rimassa
COVID-19 and liver cancer clinical trials: Not everything is lost. Liver international : official journal of the International Association for the Study of the Liver 40 (7) (2020)